NDC-11 (Package) | NDC-9 (Product) | Generic Name | Brand Name | Strength | SEER*Rx Category | Major Class | Minor Class | Administration Route | Package Effective Date | Package Discontinuation Date (Ascending) | Status |
---|---|---|---|---|---|---|---|---|---|---|---|
62584-0827-21 | 62584-0827 | Cyclosporine | Cyclosporine | Ancillary Therapy | Immunomodulator | Calcineurin Inhibitor | Oral | Dec. 11, 2009 | Sept. 30, 2011 | No Longer Used | |
65862-0149-61 | 65862-0149 | Finasteride | Finasteride | 5.0 mg/1 | Ancillary Therapy | Protective Agent | 5-alpha Reductase Inhibitor | Oral | June 30, 2011 | Oct. 25, 2011 | In Use |
00015-0502-41 | 00015-0502 | Cyclophosphamide | Cytoxan | Chemotherapy | Alkylating Agent | Nitrogen Mustard | Intravenous | June 1, 2009 | Oct. 31, 2011 | No Longer Used | |
00703-3321-91 | 00703-3321 | Octreotide Acetate | Octreotide Acetate | 500.0 ug/mL | Hormonal Therapy | Somatostatin Analog | Intravenous, Subcutaneous | Jan. 28, 2008 | Oct. 31, 2011 | In Use | |
00703-3321-94 | 00703-3321 | Octreotide Acetate | Octreotide Acetate | 500.0 ug/mL | Hormonal Therapy | Somatostatin Analog | Intravenous, Subcutaneous | Jan. 28, 2008 | Oct. 31, 2011 | In Use | |
55154-5707-05 | 55154-5707 | Dexamethasone Phosphate | Dexamethasone Sodium Phosphates | 4.0 mg/mL | Hormonal Therapy | Adrenal Glucocorticoid | Corticosteroid | Intra-Articular, Intralesional, Intramuscular, Intravenous, Soft Tissue | Sept. 30, 1990 | Oct. 31, 2011 | No Longer Used |
55154-1132-00 | 55154-1132 | Ondansetron, ondansetron hydrochloride | Zofran | 4.0 mg/1, 4.0 mg/1 | Ancillary Therapy | Antiemetic | 5HT3 Receptor Antagonist | Oral | Jan. 27, 1999 | Oct. 31, 2011 | No Longer Used |
00781-3011-80 | 00781-3011 | Ondansetron | Ondansetron | Ancillary Therapy | Antiemetic | 5HT3 Receptor Antagonist | Intramuscular, Intravenous | July 27, 2007 | Oct. 31, 2011 | No Longer Used | |
00409-4760-13 | 00409-4760 | Ondansetron Hydrochloride and Dextrose | Ondansetron Hydrochloride and Dextrose | Ancillary Therapy | Antiemetic | 5HT3 Receptor Antagonist | Intravenous | Feb. 2, 2007 | Nov. 1, 2011 | No Longer Used | |
61703-0408-22 | 61703-0408 | Methotrexate | Methotrexate | 25.0 mg/mL | Chemotherapy | Antimetabolite | Folic Acid Analog | Intra-arterial, Intramuscular, Intrathecal, Intravenous, Subcutaneous | Feb. 26, 2001 | Nov. 2, 2011 | In Use |
65862-0187-81 | 65862-0187 | Ondansetron Hydrochloride | Ondansetron Hydrochloride | 4.0 mg/1 | Ancillary Therapy | Antiemetic | 5HT3 Receptor Antagonist | Oral | July 31, 2007 | Nov. 7, 2011 | In Use |
65862-0188-59 | 65862-0188 | Ondansetron Hydrochloride | Ondansetron Hydrochloride | 8.0 mg/1 | Ancillary Therapy | Antiemetic | 5HT3 Receptor Antagonist | Oral | July 31, 2007 | Nov. 7, 2011 | In Use |
65862-0189-22 | 65862-0189 | Ondansetron Hydrochloride | Ondansetron Hydrochloride | 24.0 mg/1 | Ancillary Therapy | Antiemetic | 5HT3 Receptor Antagonist | Oral | July 31, 2007 | Nov. 7, 2011 | In Use |
54868-3004-01 | 54868-3004 | Tamoxifen Citrate | Tamoxifen Citrate | 10.0 mg/1 | Hormonal Therapy | Selective Estrogen Receptor Modulator (SERM) | Oral | April 26, 1994 | Nov. 7, 2011 | In Use | |
49349-0059-02 | 49349-0059 | Prednisone | Prednisone | 5.0 mg/1 | Hormonal Therapy | Adrenal Glucocorticoid | Corticosteroid | Oral | Nov. 9, 2010 | Nov. 10, 2011 | No Longer Used |
49349-0059-24 | 49349-0059 | Prednisone | Prednisone | 5.0 mg/1 | Hormonal Therapy | Adrenal Glucocorticoid | Corticosteroid | Oral | Nov. 9, 2010 | Nov. 10, 2011 | No Longer Used |
49884-0325-11 | 49884-0325 | Ondansetron | Zuplenz | Ancillary Therapy | Antiemetic | 5HT3 Receptor Antagonist | Oral | July 5, 2010 | Nov. 11, 2011 | No Longer Used | |
49884-0325-52 | 49884-0325 | Ondansetron | Zuplenz | Ancillary Therapy | Antiemetic | 5HT3 Receptor Antagonist | Oral | July 5, 2010 | Nov. 11, 2011 | No Longer Used | |
49349-0314-02 | 49349-0314 | Methotrexate sodium | Methotrexate Sodium | 2.5 mg/1 | Chemotherapy | Antimetabolite | Folic Acid Analog | Oral | Feb. 2, 2010 | Nov. 14, 2011 | No Longer Used |
00015-0505-41 | 00015-0505 | Cyclophosphamide | Cytoxan | Chemotherapy | Alkylating Agent | Nitrogen Mustard | Intravenous | June 1, 2009 | Nov. 30, 2011 | No Longer Used | |
00555-0904-01 | 00555-0904 | Tamoxifen Citrate | Tamoxifen Citrate | Hormonal Therapy | Selective Estrogen Receptor Modulator (SERM) | Oral | Feb. 20, 2003 | Nov. 30, 2011 | No Longer Used | ||
00555-0904-05 | 00555-0904 | Tamoxifen Citrate | Tamoxifen Citrate | Hormonal Therapy | Selective Estrogen Receptor Modulator (SERM) | Oral | Feb. 20, 2003 | Nov. 30, 2011 | No Longer Used | ||
00555-0904-14 | 00555-0904 | Tamoxifen Citrate | Tamoxifen Citrate | Hormonal Therapy | Selective Estrogen Receptor Modulator (SERM) | Oral | Feb. 20, 2003 | Nov. 30, 2011 | No Longer Used | ||
00004-0240-09 | 00004-0240 | Granisetron | Kytril | Ancillary Therapy | Antiemetic | 5HT3 Receptor Antagonist | Dec. 29, 1993 | Nov. 30, 2011 | No Longer Used | ||
68152-0104-04 | 68152-0104 | Ibritumomab Tiuxetan | Zevalin | Immunotherapy | Radioimmunotherapy | CD20 | Feb. 19, 2002 | Dec. 3, 2011 | No Longer Used |
Found 10,000 results in 2 milliseconds — Export these results